B-cell lymphoma with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma
|
disease |
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements
|
disease |
|
Neoplastic Process
|
3
|
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Abnormality of the lymph nodes
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Double expressor lymphoma
|
disease |
|
Neoplastic Process
|
4
|
|
0.070 |
None |
0.857 |
7 |
|
2016 |
2019 |
Malignant mixed salivary gland tumor
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Undifferentiated High Grade Pleomorphic Sarcoma of Bone
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Breast Lymphoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Lymphoblastic B-cell lymphoma
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Medulloblastoma, Non-WNT/Non-SHH
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Panniculitis, Lupus Erythematosus
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adult Pure Erythroid Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
5
|
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
High Grade B-Cell Lymphoma, Not Otherwise Specified
|
disease |
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Bone Fibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Neuroectodermal Tumor, Melanotic
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
acquired immunodeficiency
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
1991 |
1991 |
Oculodigitoesophagoduodenal syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Musculoskeletal Diseases; Respiratory Tract Diseases; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Disease or Syndrome
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Surface epithelial-stromal tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2016 |
2016 |
Triple hit lymphoma
|
disease |
|
Neoplastic Process
|
7
|
|
0.050 |
None |
1.000 |
5 |
|
2011 |
2019 |
Diffuse large B-cell lymphoma of central nervous system
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
7
|
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Occlusive vascular disease
|
disease |
|
Disease or Syndrome
|
7
|
1
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Aberrant Crypt Foci
|
phenotype |
Neoplasms
|
Finding
|
7
|
|
0.200 |
None |
1.000 |
1 |
|
1993 |
1993 |
metastatic pheochromocytoma
|
disease |
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Serous cystadenoma, borderline malignancy
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
2
|
0.010 |
None |
1.000 |
1 |
|
1992 |
1992 |
Dysplasia of larynx
|
disease |
Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Gastrointestinal lymphoma
|
disease |
Digestive System Diseases; Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |